> Japan's Eisai has withdrawn its European application for Aricept as a treatment for Alzheimer's after regulators asked for more data. Report [1]
> Novelos Therapeutics is planning a $15 million private placement. Release [2]
> The FDA has approved GlaxoSmithKline's antibacterial Altabax. Report [3]
> India's Lupin Pharmaceuticals has received FDA approval for a new formulation of its anti-infective Suprax. Release [4]
> Alkermes announced that the FDA has approved a new dose of risperidone for schizophrenia. Report [5]
And Finally... Indian officials are on alert after an outbreaK of bird flu in Bangladesh. Report [6]
Links:
[1] http://www.reuters.com/article/health-SP/idUST34702420070413
[2] http://www.fiercebiotech.com/node/6464
[3] http://www.upi.com/Health_Business/Briefing/2007/04/13/fda_approves_glaxosmithklines_altabax/
[4] http://sev.prnewswire.com/health-care-hospitals/20070412/NETH08012042007-1.html
[5] http://www.reuters.com/article/governmentFilingsNews/idUSWNAS626820070413
[6] http://www.telegraphindia.com/1070412/asp/northeast/story_7635021.asp